Key Findings
The Europe newborn screening market raised $xx million in the year 2017. Between the projected years of 2019-2027, the market is forecasted to showcase a CAGR of 13.22% and generate $xx million by 2027.

Market Insights
Newborn screening market is on a surging trend in Europe, owing to factors like government programs supporting newborn screening, the rising prevalence of sickle cell diseases in newborn babies, government’s mandatory regulation supporting newborn testing and technological advancement in newborn screening techniques.

The U.K market accounted for a significant revenue share in 2018. The German market is progressing at a considerable pace. Moreover, as per the World Health Organization in Germany, newborn hearing screening has been compulsory with a goal to diagnose congenital hearing loss before the end of the third month of life. Hence, the incentives for newborn screening in Germany would raise the adoption for the newborn screening techniques in the country thereby making a positive impact.

Competitive Insights
Major players like Sciex, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Cardinal Health Inc., GE Healthcare Limited, Agilent Technologies Inc., Masimo Corporation, Natus Medical Incorporated, Medtronic PLC, Thermo Fisher Scientific Inc., Neogen Labs Pvt. Ltd., Perkinelmer Inc., Zentech S.A., Waters Corporation and Trivitron Healthcare have established themselves in this market that have been discussed in the report.